肺癌分期与诊断的质量差距及比较效果
该回顾性队列纳入2004至2013年SEER或德州癌症登记Medicare链接数据库中15,914例T1-3N1-3M0肺癌患者,比较以纵隔采样为首个侵入性检查(指南一致)与其他策略的实践模式与结局。指南一致率从23%升至34%(P<.001),且与更少开胸术、CT引导活检及并发症相关;支气管内超声引导经支气管针吸活检(EBUS-TBNA)使用增加但质量差距仍存。
要点
- 指南一致(纵隔采样优先)与更少检查次数和并发症相关。
- EBUS-TBNA使用从0.1%升至25%,指南一致率从23%升至34%。
- 质量差距包括未优先或未采样纵隔、开胸术过度使用。
核心结论
- 以纵隔采样为首个侵入性检查的指南一致诊疗与更少检查次数和并发症相关。
- EBUS-TBNA引入后质量差距缩小但仍持续存在。
研究设计与样本
- 回顾性队列研究,纳入2004至2013年SEER或德州癌症登记Medicare链接数据库中15,914例T1-3N1-3M0肺癌患者。
- 以纵隔采样为首个侵入性检查定义为指南一致,其余为指南不一致;采用倾向性匹配比较检查次数,多因素logistic回归比较并发症发生率。
主要发现
- 指南一致率从2004年23%升至2013年34%(P<.001)。
- EBUS-TBNA使用从0.1%升至25%(P<.001),纵隔采样从54%升至64%(P<.0001)。
- 指南一致组开胸术38% vs 71%(P<.001)、CT引导活检10% vs 75%(P<.001)更少,经支气管针吸活检59% vs 12%(P<.001)更多。
- 指南一致组气胸5.1% vs 22%(P<.001)、胸管0.9% vs 4.4%(P<.001)、出血3.5% vs 5.8%(P<.001)、呼吸衰竭2.7% vs 3.7%(P=.047)更少。
- 支气管镜纵隔采样并发症少于外科纵隔采样。
关键数值与推荐
- 指南推荐疑似肺癌伴纵隔淋巴结肿大患者首先进行纵隔采样。
- 指南一致诊疗与更少开胸术、CT引导活检及气胸、胸管、出血、呼吸衰竭相关。
临床怎么用
- 对疑似肺癌伴纵隔淋巴结肿大患者,应优先采用纵隔采样作为首个侵入性检查。
- 优先选择支气管镜纵隔采样(如EBUS-TBNA)而非外科纵隔采样以减少并发症。
- 需关注并改进未优先采样纵隔、未采样纵隔及开胸术过度使用等质量差距。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines recommend mediastinal sampling first for patients with mediastinal lymphadenopathy with suspected lung cancer. The objective of this study was to describe practice patterns and outcomes of diagnostic strategies in patients with lung cancer. METHODS: This study included a retrospective cohort of 15,914 patients with lung cancer with T1-3N1-3M0 disease diagnosed from 2004 to 2013 in the National Cancer Institute's Surveillance, Epidemiology, and End Results or Texas Cancer Registry Medicare-linked databases. Patients who had mediastinal sampling as their first invasive test were classified as guideline consistent; all others were guideline inconsistent. Propensity matching was used to compare the number of tests performed, and multivariable logistic regression was used to compare the incidence of complications. RESULTS: Guideline-consistent care increased from 23% to 34% of patients from 2004 to 2013 (P < .001). Use of endobronchial ultrasound-guided transbronchial needle aspiration increased from 0.1% to 25% of all patients (P < .001), and mediastinal sampling increased from 54% to 64% (P < .0001). Guideline-consistent care was associated with fewer thoracotomies (38% vs 71%; P < .001) and CT scan-guided biopsies (10% vs 75%; P < .001) than guideline-inconsistent care but more transbronchial needle aspirations (59% vs 12%; P < .001). Guideline-consistent care was associated with fewer pneumothoraxes (5.1% vs 22%; P < .001), chest tubes (0.9% vs 4.4%; P < .001), hemorrhages (3.5% vs 5.8%; P < .001), and respiratory failure events (2.7% vs 3.7%; P = .047) than guideline-inconsistent care. Bronchoscopic mediastinal sampling was associated with fewer complications than surgical mediastinal sampling. CONCLUSIONS: Guideline-consistent care with mediastinal sampling first was associated with fewer tests and complications. Quality gaps decreased with the introduction of endobronchial ultrasound-guided transbronchial needle aspiration but persist. Gaps include failure to sample the mediastinum first, failure to sample the mediastinum at all, and overuse of thoracotomy.
引用
- Ost DE, Niu J, Zhao H, et al. Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis. Chest. 2019. PMID: 31610159. doi:10.1016/j.chest.2019.09.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。